Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD

BACKGROUND: To evaluate changes in central macular thickness (CMT) and visual outcome in patients with neovascular age-related macular degeneration (AMD) treated initially with bevacizumab and subsequently switched to either aflibercept or ranibizumab. METHODS: Observational clinical study was perfo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Ophthalmol
Hoofdauteurs: Waizel, Maria, Todorova, Margarita G., Masyk, Michael, Wolf, Katharina, Rickmann, Annekatrin, Helaiwa, Khaled, Blanke, Björn R., Szurman, Peter
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2017
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5442868/
https://ncbi.nlm.nih.gov/pubmed/28535756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-017-0471-x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items